NATCO Pharma Limited

NATCOPHARM.NS·NSE·Healthcare
Compare
796.60+7.85 (+1.00%)today
At close: Nov 5, 3:30 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close788.75
Open797.00
Day range789.65809.90
52-week range773.601,226.80
Off day high−1.64%
Off 52-week high−35.07%
Volume633.77K
Avg. volume (3M)465.39K
Market cap156.27B
EPS (TTM)63.37
Forward P/E16.82
P/E ratio (TTM)12.57
Dividend yield0.75% (5.95)
Beta (5Y)0.18
Shares outstanding196.17M
Short interest—
Earnings dateNov 13, 2026
Analyst target1,004.44
Profit margin32.84%

Against its peers

Compare in full ›
NATCOPHARM.NS IPCALAB.NS GRANULES.BO SHILPAMED.NS 000597.SZ IOLCP.NS
Market cap 156.27B 494.62B 192.80B 184.68B 6.41B 55.51B
P/E (TTM) 12.6 37.8 35.3 66.7 34.5 27.3
Forward P/E 16.8 27.7 26.5 45.3 — 17.5
Price/book 1.5 6.1 4.8 7.1 1.2 2.9
Dividend yield 0.75% 0.30% 0.26% 0.06% 1.23% 0.54%
1-year change −4.67% +51.13% +0.63% +160.71% −20.28% +87.93%
Today +1.00% −1.14% −0.01% +1.41% +0.22% +2.91%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Business Upturn·Positive

Natco Pharma closes Rs.12,794 million rights issue

Natco Pharma Limited completes Rs.12,794 million rights issue, closing on October 22, 2026, after the board's approval in September. Natco Pharma closes Rs.12,794 million rights issue Natco Pharma Limited, the renowned pharmaceutical…

Univest·Negative

Natco Pharma Ltd. 52 Week Low Streak: key stock context

Natco Pharma Ltd. 52 Week Low Streak has now extended to a second straight session, with the stock trading within 2% of its 52-week low across both days. Across the streak, the share price has moved down 2.23%, and the latest trading print…

Digital Health News·Positive

NATCO Pharma Raises Investment in eGenesis to $16.70 Mn

NATCO Pharma Limited has increased its proposed investment in US-based biotechnology company eGenesis, Inc. to $16.70 million from the previously announced $14 million, according to a regulatory filing. The investment will be made through…

From the 4Search news index, newest first.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance